Utah Medical Products (NASDAQ:UTMD) Stock Price Passes Above 200 Day Moving Average of $68.90

Utah Medical Products, Inc. (NASDAQ:UTMD) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $68.90 and traded as high as $69.30. Utah Medical Products shares last traded at $68.57, with a volume of 6,899 shares trading hands.

Utah Medical Products Trading Up 1.5 %

The stock has a market capitalization of $241.91 million, a PE ratio of 15.24 and a beta of 0.06. The business has a fifty day moving average price of $68.07 and a 200-day moving average price of $68.90.

Utah Medical Products (NASDAQ:UTMD) last issued its earnings results on Thursday, July 25th. The medical instruments supplier reported $0.98 earnings per share (EPS) for the quarter. Utah Medical Products had a return on equity of 12.41% and a net margin of 33.56%. The business had revenue of $10.40 million during the quarter.

Utah Medical Products Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 4th. Investors of record on Friday, September 20th will be issued a dividend of $0.30 per share. This represents a $1.20 annualized dividend and a dividend yield of 1.75%. The ex-dividend date is Friday, September 20th. Utah Medical Products’s dividend payout ratio is currently 26.67%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Northwest Financial Advisors bought a new position in Utah Medical Products during the 4th quarter worth approximately $25,000. Allspring Global Investments Holdings LLC bought a new position in shares of Utah Medical Products in the second quarter worth approximately $83,000. Victory Capital Management Inc. increased its stake in shares of Utah Medical Products by 124.4% in the second quarter. Victory Capital Management Inc. now owns 2,673 shares of the medical instruments supplier’s stock worth $179,000 after buying an additional 1,482 shares during the period. EntryPoint Capital LLC raised its holdings in Utah Medical Products by 124.1% during the 1st quarter. EntryPoint Capital LLC now owns 3,240 shares of the medical instruments supplier’s stock valued at $230,000 after buying an additional 1,794 shares during the last quarter. Finally, BNP Paribas Financial Markets boosted its position in Utah Medical Products by 101.7% during the 4th quarter. BNP Paribas Financial Markets now owns 3,766 shares of the medical instruments supplier’s stock valued at $317,000 after buying an additional 1,899 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.